Mariner’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Sell |
88,284
-19,457
| -18% | -$98.5K | ﹤0.01% | 2421 |
|
|
2025
Q1 | $570K | Sell |
107,741
-3,322
| -3% | -$17.6K | ﹤0.01% | 2104 |
|
|
2024
Q4 | $751K | Buy |
111,063
+27,499
| +33% | +$186K | ﹤0.01% | 1853 |
|
|
2024
Q3 | $551K | Buy |
83,564
+2,469
| +3% | +$16.3K | ﹤0.01% | 2049 |
|
|
2024
Q2 | $608K | Buy |
81,095
+1,192
| +1% | +$8.94K | ﹤0.01% | 1902 |
|
|
2024
Q1 | $797K | Buy |
79,903
+52
| +0.1% | +$518 | ﹤0.01% | 1673 |
|
|
2023
Q4 | $787K | Sell |
79,851
-604
| -0.8% | -$5.96K | ﹤0.01% | 1609 |
|
|
2023
Q3 | $615K | Sell |
80,455
-50,575
| -39% | -$387K | ﹤0.01% | 1634 |
|
|
2023
Q2 | $979K | Sell |
131,030
-61,126
| -32% | -$457K | ﹤0.01% | 1326 |
|
|
2023
Q1 | $1.28M | Sell |
192,156
-6,569
| -3% | -$43.8K | ﹤0.01% | 1151 |
|
|
2022
Q4 | $1.53M | Sell |
198,725
-763
| -0.4% | -$5.88K | ﹤0.01% | 1033 |
|
|
2022
Q3 | $2.12M | Buy |
199,488
+24,951
| +14% | +$266K | 0.01% | 749 |
|
|
2022
Q2 | $1.42M | Buy |
174,537
+146,418
| +521% | +$1.19M | 0.01% | 802 |
|
|
2022
Q1 | $201K | Buy |
+28,119
| New | +$201K | ﹤0.01% | 1378 |
|